These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 32308350)

  • 1. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
    Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
    World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
    Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
    Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
    Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
    Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
    Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of neutrophil/prealbumin ratio for intrahepatic cholangiocarcinoma undergoing curative resection.
    Huang XT; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    HPB (Oxford); 2018 Dec; 20(12):1215-1222. PubMed ID: 30078755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
    Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
    Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative risk score for prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma: Report of a collaborative, international-based, external validation study.
    Brustia R; Langella S; Kawai T; Fonseca GM; Schielke A; Colli F; Resende V; Fleres F; Roulin D; Leyman P; Giacomoni A; Granger B; Fartoux L; De Carlis L; Demartines N; Sommacale D; Sanches MD; Patrono D; Detry O; Herman P; Okumura S; Ferrero A; Scatton O;
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):560-571. PubMed ID: 31718919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy.
    Liu L; Wang W; Zhang Y; Long J; Zhang Z; Li Q; Chen B; Li S; Hua Y; Shen S; Peng B
    Cancer Res Treat; 2018 Apr; 50(2):538-550. PubMed ID: 28602056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma.
    Tsilimigras DI; Mehta R; Aldrighetti L; Poultsides GA; Maithel SK; Martel G; Shen F; Koerkamp BG; Endo I; Pawlik TM;
    J Am Coll Surg; 2020 Apr; 230(4):381-391.e2. PubMed ID: 32014569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
    Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma.
    Zhu H; Wang L; Wang M; He X; Xu W; Zhu W; Zhao Y; Wang L
    Am J Surg; 2021 Aug; 222(2):383-389. PubMed ID: 33388133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection.
    Li H; Wang JJ; Zhang M; Ren B; Li JX; Xu L; Wu H
    World J Gastrointest Oncol; 2020 Apr; 12(4):467-482. PubMed ID: 32368324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
    Kano H; Midorikawa Y; Song P; Nakayama H; Moriguchi M; Higaki T; Tsuji S; Takayama T
    Biosci Trends; 2020 Sep; 14(4):304-309. PubMed ID: 32507777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
    Buettner S; Spolverato G; Kimbrough CW; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Koerkamp BG; Pawlik TM
    Surgery; 2018 Sep; 164(3):411-418. PubMed ID: 29903509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma.
    Zhou SL; Xin HY; Sun RQ; Zhou ZJ; Hu ZQ; Luo CB; Wang PC; Li J; Fan J; Zhou J
    JAMA Surg; 2022 Jan; 157(1):59-65. PubMed ID: 34730772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour burden score combined with albumin-to-alkaline phosphatase ratio predicts prognosis in patients with intrahepatic cholangiocarcinoma.
    Wang S; Liu M; Xiang L; Qiu H; Cheng L; Huang Z; Wen T; Xie W; Li S; Zhang C; Wang G; Li H; Li D
    J Cell Mol Med; 2024 Jul; 28(13):e18530. PubMed ID: 38961673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.